News
Phase 3 trial: Maribavir yields post-transplant benefits
Study findings “provide supportive evidence of the potential for long-term benefit” with maribavir for the treatment of post-transplant CMV.
News
Novel fluorescence guidance improves lumpectomy outcomes
Pegulicianine (Lumisight), an investigational and activatable fluorescent imaging agent used with a novel direct visualization system, helped...
News
Motixafortide may improve MM outcomes
A new drug approval for motixafortide is currently under review by the Food and Drug Administration.
News
FDA approves new Merkel cell carcinoma treatment
This marks the first regulatory approval for retifanlimab-dlwr, a PD-1 inhibitor.
News
Depression tied to inflammation and survival in lung cancer
A new study’s findings underscore the importance of assessing and treating depression in patients with cancer, particularly given the high rate of...
News
Venetoclax shows promise for r/r hairy cell leukemia
Italian study suggests benefits of administering venetoclax for patients with r/r cases of hairy cell leukemia, a rare blood cancer,
News
FDA strengthens mammography regulations: Final rule
A final rule requires that mammography facilities notify patients about the density of their breasts.
News
Phase 3 results: Ponatinib bests imatinib for Ph+ALL
First prospective study of third-generation TKI ponatinib showed its comparative benefit for the most common subtype of adult ALL.
News
Popular book by USC oncologist pulled because of plagiarism
The Los Angeles Times reported earlier this week that it identified at least 95 instances of plagiarism by Dr. David B. Agus.
News
‘Exciting’: Post-SCT, antiviral T-cell therapy shows promise
In a phase 2 study, an off-the-shelf investigational therapy showed safety and efficacy against six viruses after allogeneic stem cell transplant...
News
FDA approves pirtobrutinib for r/r mantle cell lymphoma
Pirtobrutinib for relapsed or refractory mantle cell lymphoma has been approved by the Food and Drug Administration.
News
FDA calls for withdrawal of multiple myeloma drug Pepaxto
A confirmatory trial to show clinical benefit raised concerns about safety.
News
Fungi inside cancer cells: ‘A new and emerging hallmark’
Fungi were detected in all cancer types studied and were often intracellular.
News
One-third of pancreatic cancer diagnoses missed on scans
The time window for curative surgery is often short, and missing the diagnosis can result in worse clinical outcomes.
News
Cost paramount when choosing metastatic breast cancer treatment
“Our analysis provides quantifiable evidence to help providers choose lower priced, but equally effective sequences of drugs.”